CANCER LETT 润色咨询

CANCER LETTERS

出版年份:1975 年文章数:4498 投稿命中率: 开通期刊会员,数据随心看

出版周期:Biweekly 自引率:3.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=921392, encodeId=693192139203, content=审稿速度:1.0<br>偏重的研究方向:白血病<br>经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200618/4c27fa23bb6a44a49a51871bc8fe6190/d1c485af61c8460ba037d35b90d34b04.jpg, createdBy=e5c95263798, createdName=嚯嚯嚯1971, createdTime=Sat Jan 30 15:57:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114616, encodeId=19812114616ba, content=我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13335609339, createdName=ms5000002011942975, createdTime=Tue Feb 14 19:24:48 CST 2023, time=2023-02-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2091659, encodeId=19db209165937, content=求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon Oct 03 23:21:05 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184614, encodeId=85ed218461406, content=刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76200857, createdName=195092_8956, createdTime=Mon Jan 29 11:53:34 CST 2024, time=2024-01-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2171958, encodeId=1f2321e19589a, content=09/10/2023 投稿<br>09/20/2023 under review <br>11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=651e8489728, createdName=ms2000000020645198, createdTime=Wed Nov 29 22:04:44 CST 2023, time=2023-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177808, encodeId=dc7f21e7808b8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;细胞生物学<br>经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e088428858, createdName=ms3000001523418875, createdTime=Thu Dec 28 16:05:00 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169383, encodeId=23cb2169383eb, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:10/21/2023 投稿<br>10/23/2023 改格式<br>10/23/2023 分配3个编辑<br>10/26/2023 Under Review<br>11/07/2023 Required Reviews Completed<br>11/10/2023 Decision in Process<br>11/13/2023 Major Revision 给了1个月修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Sat Nov 18 21:22:58 CST 2023, time=2023-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173295, encodeId=0ea421e329515, content=偏重的研究方向:肿瘤<br>经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Wed Dec 06 15:52:11 CST 2023, time=2023-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170381, encodeId=071521e0381cc, content=请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=记录投稿经历, createdTime=Thu Nov 23 00:51:44 CST 2023, time=2023-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180385, encodeId=148821803851f, content=投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=Jagger, createdTime=Tue Jan 09 23:30:30 CST 2024, time=2024-01-09, status=1, ipAttribution=天津)]
    2021-01-30 嚯嚯嚯1971

    审稿速度:1.0
    偏重的研究方向:白血病
    经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。

    13

    展开13条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=921392, encodeId=693192139203, content=审稿速度:1.0<br>偏重的研究方向:白血病<br>经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200618/4c27fa23bb6a44a49a51871bc8fe6190/d1c485af61c8460ba037d35b90d34b04.jpg, createdBy=e5c95263798, createdName=嚯嚯嚯1971, createdTime=Sat Jan 30 15:57:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114616, encodeId=19812114616ba, content=我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13335609339, createdName=ms5000002011942975, createdTime=Tue Feb 14 19:24:48 CST 2023, time=2023-02-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2091659, encodeId=19db209165937, content=求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon Oct 03 23:21:05 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184614, encodeId=85ed218461406, content=刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76200857, createdName=195092_8956, createdTime=Mon Jan 29 11:53:34 CST 2024, time=2024-01-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2171958, encodeId=1f2321e19589a, content=09/10/2023 投稿<br>09/20/2023 under review <br>11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=651e8489728, createdName=ms2000000020645198, createdTime=Wed Nov 29 22:04:44 CST 2023, time=2023-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177808, encodeId=dc7f21e7808b8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;细胞生物学<br>经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e088428858, createdName=ms3000001523418875, createdTime=Thu Dec 28 16:05:00 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169383, encodeId=23cb2169383eb, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:10/21/2023 投稿<br>10/23/2023 改格式<br>10/23/2023 分配3个编辑<br>10/26/2023 Under Review<br>11/07/2023 Required Reviews Completed<br>11/10/2023 Decision in Process<br>11/13/2023 Major Revision 给了1个月修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Sat Nov 18 21:22:58 CST 2023, time=2023-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173295, encodeId=0ea421e329515, content=偏重的研究方向:肿瘤<br>经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Wed Dec 06 15:52:11 CST 2023, time=2023-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170381, encodeId=071521e0381cc, content=请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=记录投稿经历, createdTime=Thu Nov 23 00:51:44 CST 2023, time=2023-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180385, encodeId=148821803851f, content=投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=Jagger, createdTime=Tue Jan 09 23:30:30 CST 2024, time=2024-01-09, status=1, ipAttribution=天津)]
    2023-02-14 ms5000002011942975 来自河南省

    我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=921392, encodeId=693192139203, content=审稿速度:1.0<br>偏重的研究方向:白血病<br>经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200618/4c27fa23bb6a44a49a51871bc8fe6190/d1c485af61c8460ba037d35b90d34b04.jpg, createdBy=e5c95263798, createdName=嚯嚯嚯1971, createdTime=Sat Jan 30 15:57:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114616, encodeId=19812114616ba, content=我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13335609339, createdName=ms5000002011942975, createdTime=Tue Feb 14 19:24:48 CST 2023, time=2023-02-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2091659, encodeId=19db209165937, content=求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon Oct 03 23:21:05 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184614, encodeId=85ed218461406, content=刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76200857, createdName=195092_8956, createdTime=Mon Jan 29 11:53:34 CST 2024, time=2024-01-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2171958, encodeId=1f2321e19589a, content=09/10/2023 投稿<br>09/20/2023 under review <br>11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=651e8489728, createdName=ms2000000020645198, createdTime=Wed Nov 29 22:04:44 CST 2023, time=2023-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177808, encodeId=dc7f21e7808b8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;细胞生物学<br>经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e088428858, createdName=ms3000001523418875, createdTime=Thu Dec 28 16:05:00 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169383, encodeId=23cb2169383eb, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:10/21/2023 投稿<br>10/23/2023 改格式<br>10/23/2023 分配3个编辑<br>10/26/2023 Under Review<br>11/07/2023 Required Reviews Completed<br>11/10/2023 Decision in Process<br>11/13/2023 Major Revision 给了1个月修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Sat Nov 18 21:22:58 CST 2023, time=2023-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173295, encodeId=0ea421e329515, content=偏重的研究方向:肿瘤<br>经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Wed Dec 06 15:52:11 CST 2023, time=2023-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170381, encodeId=071521e0381cc, content=请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=记录投稿经历, createdTime=Thu Nov 23 00:51:44 CST 2023, time=2023-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180385, encodeId=148821803851f, content=投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=Jagger, createdTime=Tue Jan 09 23:30:30 CST 2024, time=2024-01-09, status=1, ipAttribution=天津)]
    2022-10-03 雨落殇殇

    求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=921392, encodeId=693192139203, content=审稿速度:1.0<br>偏重的研究方向:白血病<br>经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200618/4c27fa23bb6a44a49a51871bc8fe6190/d1c485af61c8460ba037d35b90d34b04.jpg, createdBy=e5c95263798, createdName=嚯嚯嚯1971, createdTime=Sat Jan 30 15:57:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114616, encodeId=19812114616ba, content=我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13335609339, createdName=ms5000002011942975, createdTime=Tue Feb 14 19:24:48 CST 2023, time=2023-02-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2091659, encodeId=19db209165937, content=求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon Oct 03 23:21:05 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184614, encodeId=85ed218461406, content=刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76200857, createdName=195092_8956, createdTime=Mon Jan 29 11:53:34 CST 2024, time=2024-01-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2171958, encodeId=1f2321e19589a, content=09/10/2023 投稿<br>09/20/2023 under review <br>11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=651e8489728, createdName=ms2000000020645198, createdTime=Wed Nov 29 22:04:44 CST 2023, time=2023-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177808, encodeId=dc7f21e7808b8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;细胞生物学<br>经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e088428858, createdName=ms3000001523418875, createdTime=Thu Dec 28 16:05:00 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169383, encodeId=23cb2169383eb, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:10/21/2023 投稿<br>10/23/2023 改格式<br>10/23/2023 分配3个编辑<br>10/26/2023 Under Review<br>11/07/2023 Required Reviews Completed<br>11/10/2023 Decision in Process<br>11/13/2023 Major Revision 给了1个月修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Sat Nov 18 21:22:58 CST 2023, time=2023-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173295, encodeId=0ea421e329515, content=偏重的研究方向:肿瘤<br>经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Wed Dec 06 15:52:11 CST 2023, time=2023-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170381, encodeId=071521e0381cc, content=请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=记录投稿经历, createdTime=Thu Nov 23 00:51:44 CST 2023, time=2023-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180385, encodeId=148821803851f, content=投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=Jagger, createdTime=Tue Jan 09 23:30:30 CST 2024, time=2024-01-09, status=1, ipAttribution=天津)]
    2024-01-29 195092_8956 来自香港

    刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=921392, encodeId=693192139203, content=审稿速度:1.0<br>偏重的研究方向:白血病<br>经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200618/4c27fa23bb6a44a49a51871bc8fe6190/d1c485af61c8460ba037d35b90d34b04.jpg, createdBy=e5c95263798, createdName=嚯嚯嚯1971, createdTime=Sat Jan 30 15:57:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114616, encodeId=19812114616ba, content=我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13335609339, createdName=ms5000002011942975, createdTime=Tue Feb 14 19:24:48 CST 2023, time=2023-02-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2091659, encodeId=19db209165937, content=求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon Oct 03 23:21:05 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184614, encodeId=85ed218461406, content=刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76200857, createdName=195092_8956, createdTime=Mon Jan 29 11:53:34 CST 2024, time=2024-01-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2171958, encodeId=1f2321e19589a, content=09/10/2023 投稿<br>09/20/2023 under review <br>11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=651e8489728, createdName=ms2000000020645198, createdTime=Wed Nov 29 22:04:44 CST 2023, time=2023-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177808, encodeId=dc7f21e7808b8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;细胞生物学<br>经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e088428858, createdName=ms3000001523418875, createdTime=Thu Dec 28 16:05:00 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169383, encodeId=23cb2169383eb, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:10/21/2023 投稿<br>10/23/2023 改格式<br>10/23/2023 分配3个编辑<br>10/26/2023 Under Review<br>11/07/2023 Required Reviews Completed<br>11/10/2023 Decision in Process<br>11/13/2023 Major Revision 给了1个月修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Sat Nov 18 21:22:58 CST 2023, time=2023-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173295, encodeId=0ea421e329515, content=偏重的研究方向:肿瘤<br>经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Wed Dec 06 15:52:11 CST 2023, time=2023-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170381, encodeId=071521e0381cc, content=请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=记录投稿经历, createdTime=Thu Nov 23 00:51:44 CST 2023, time=2023-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180385, encodeId=148821803851f, content=投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=Jagger, createdTime=Tue Jan 09 23:30:30 CST 2024, time=2024-01-09, status=1, ipAttribution=天津)]
    2023-11-29 ms2000000020645198 来自北京

    09/10/2023 投稿
    09/20/2023 under review
    11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=921392, encodeId=693192139203, content=审稿速度:1.0<br>偏重的研究方向:白血病<br>经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200618/4c27fa23bb6a44a49a51871bc8fe6190/d1c485af61c8460ba037d35b90d34b04.jpg, createdBy=e5c95263798, createdName=嚯嚯嚯1971, createdTime=Sat Jan 30 15:57:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114616, encodeId=19812114616ba, content=我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13335609339, createdName=ms5000002011942975, createdTime=Tue Feb 14 19:24:48 CST 2023, time=2023-02-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2091659, encodeId=19db209165937, content=求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon Oct 03 23:21:05 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184614, encodeId=85ed218461406, content=刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76200857, createdName=195092_8956, createdTime=Mon Jan 29 11:53:34 CST 2024, time=2024-01-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2171958, encodeId=1f2321e19589a, content=09/10/2023 投稿<br>09/20/2023 under review <br>11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=651e8489728, createdName=ms2000000020645198, createdTime=Wed Nov 29 22:04:44 CST 2023, time=2023-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177808, encodeId=dc7f21e7808b8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;细胞生物学<br>经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e088428858, createdName=ms3000001523418875, createdTime=Thu Dec 28 16:05:00 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169383, encodeId=23cb2169383eb, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:10/21/2023 投稿<br>10/23/2023 改格式<br>10/23/2023 分配3个编辑<br>10/26/2023 Under Review<br>11/07/2023 Required Reviews Completed<br>11/10/2023 Decision in Process<br>11/13/2023 Major Revision 给了1个月修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Sat Nov 18 21:22:58 CST 2023, time=2023-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173295, encodeId=0ea421e329515, content=偏重的研究方向:肿瘤<br>经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Wed Dec 06 15:52:11 CST 2023, time=2023-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170381, encodeId=071521e0381cc, content=请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=记录投稿经历, createdTime=Thu Nov 23 00:51:44 CST 2023, time=2023-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180385, encodeId=148821803851f, content=投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=Jagger, createdTime=Tue Jan 09 23:30:30 CST 2024, time=2024-01-09, status=1, ipAttribution=天津)]
    2023-12-28 ms3000001523418875

    审稿速度:4.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤;细胞生物学
    经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=921392, encodeId=693192139203, content=审稿速度:1.0<br>偏重的研究方向:白血病<br>经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200618/4c27fa23bb6a44a49a51871bc8fe6190/d1c485af61c8460ba037d35b90d34b04.jpg, createdBy=e5c95263798, createdName=嚯嚯嚯1971, createdTime=Sat Jan 30 15:57:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114616, encodeId=19812114616ba, content=我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13335609339, createdName=ms5000002011942975, createdTime=Tue Feb 14 19:24:48 CST 2023, time=2023-02-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2091659, encodeId=19db209165937, content=求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon Oct 03 23:21:05 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184614, encodeId=85ed218461406, content=刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76200857, createdName=195092_8956, createdTime=Mon Jan 29 11:53:34 CST 2024, time=2024-01-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2171958, encodeId=1f2321e19589a, content=09/10/2023 投稿<br>09/20/2023 under review <br>11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=651e8489728, createdName=ms2000000020645198, createdTime=Wed Nov 29 22:04:44 CST 2023, time=2023-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177808, encodeId=dc7f21e7808b8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;细胞生物学<br>经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e088428858, createdName=ms3000001523418875, createdTime=Thu Dec 28 16:05:00 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169383, encodeId=23cb2169383eb, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:10/21/2023 投稿<br>10/23/2023 改格式<br>10/23/2023 分配3个编辑<br>10/26/2023 Under Review<br>11/07/2023 Required Reviews Completed<br>11/10/2023 Decision in Process<br>11/13/2023 Major Revision 给了1个月修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Sat Nov 18 21:22:58 CST 2023, time=2023-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173295, encodeId=0ea421e329515, content=偏重的研究方向:肿瘤<br>经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Wed Dec 06 15:52:11 CST 2023, time=2023-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170381, encodeId=071521e0381cc, content=请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=记录投稿经历, createdTime=Thu Nov 23 00:51:44 CST 2023, time=2023-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180385, encodeId=148821803851f, content=投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=Jagger, createdTime=Tue Jan 09 23:30:30 CST 2024, time=2024-01-09, status=1, ipAttribution=天津)]
    2023-11-18 ms3000000772221561 来自上海

    审稿速度:1.0
    偏重的研究方向:肿瘤
    经验分享:10/21/2023 投稿
    10/23/2023 改格式
    10/23/2023 分配3个编辑
    10/26/2023 Under Review
    11/07/2023 Required Reviews Completed
    11/10/2023 Decision in Process
    11/13/2023 Major Revision 给了1个月修

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=921392, encodeId=693192139203, content=审稿速度:1.0<br>偏重的研究方向:白血病<br>经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200618/4c27fa23bb6a44a49a51871bc8fe6190/d1c485af61c8460ba037d35b90d34b04.jpg, createdBy=e5c95263798, createdName=嚯嚯嚯1971, createdTime=Sat Jan 30 15:57:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114616, encodeId=19812114616ba, content=我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13335609339, createdName=ms5000002011942975, createdTime=Tue Feb 14 19:24:48 CST 2023, time=2023-02-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2091659, encodeId=19db209165937, content=求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon Oct 03 23:21:05 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184614, encodeId=85ed218461406, content=刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76200857, createdName=195092_8956, createdTime=Mon Jan 29 11:53:34 CST 2024, time=2024-01-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2171958, encodeId=1f2321e19589a, content=09/10/2023 投稿<br>09/20/2023 under review <br>11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=651e8489728, createdName=ms2000000020645198, createdTime=Wed Nov 29 22:04:44 CST 2023, time=2023-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177808, encodeId=dc7f21e7808b8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;细胞生物学<br>经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e088428858, createdName=ms3000001523418875, createdTime=Thu Dec 28 16:05:00 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169383, encodeId=23cb2169383eb, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:10/21/2023 投稿<br>10/23/2023 改格式<br>10/23/2023 分配3个编辑<br>10/26/2023 Under Review<br>11/07/2023 Required Reviews Completed<br>11/10/2023 Decision in Process<br>11/13/2023 Major Revision 给了1个月修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Sat Nov 18 21:22:58 CST 2023, time=2023-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173295, encodeId=0ea421e329515, content=偏重的研究方向:肿瘤<br>经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Wed Dec 06 15:52:11 CST 2023, time=2023-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170381, encodeId=071521e0381cc, content=请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=记录投稿经历, createdTime=Thu Nov 23 00:51:44 CST 2023, time=2023-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180385, encodeId=148821803851f, content=投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=Jagger, createdTime=Tue Jan 09 23:30:30 CST 2024, time=2024-01-09, status=1, ipAttribution=天津)]
    2023-12-06 沧海医僧笑 来自重庆

    偏重的研究方向:肿瘤
    经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=921392, encodeId=693192139203, content=审稿速度:1.0<br>偏重的研究方向:白血病<br>经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200618/4c27fa23bb6a44a49a51871bc8fe6190/d1c485af61c8460ba037d35b90d34b04.jpg, createdBy=e5c95263798, createdName=嚯嚯嚯1971, createdTime=Sat Jan 30 15:57:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114616, encodeId=19812114616ba, content=我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13335609339, createdName=ms5000002011942975, createdTime=Tue Feb 14 19:24:48 CST 2023, time=2023-02-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2091659, encodeId=19db209165937, content=求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon Oct 03 23:21:05 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184614, encodeId=85ed218461406, content=刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76200857, createdName=195092_8956, createdTime=Mon Jan 29 11:53:34 CST 2024, time=2024-01-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2171958, encodeId=1f2321e19589a, content=09/10/2023 投稿<br>09/20/2023 under review <br>11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=651e8489728, createdName=ms2000000020645198, createdTime=Wed Nov 29 22:04:44 CST 2023, time=2023-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177808, encodeId=dc7f21e7808b8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;细胞生物学<br>经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e088428858, createdName=ms3000001523418875, createdTime=Thu Dec 28 16:05:00 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169383, encodeId=23cb2169383eb, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:10/21/2023 投稿<br>10/23/2023 改格式<br>10/23/2023 分配3个编辑<br>10/26/2023 Under Review<br>11/07/2023 Required Reviews Completed<br>11/10/2023 Decision in Process<br>11/13/2023 Major Revision 给了1个月修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Sat Nov 18 21:22:58 CST 2023, time=2023-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173295, encodeId=0ea421e329515, content=偏重的研究方向:肿瘤<br>经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Wed Dec 06 15:52:11 CST 2023, time=2023-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170381, encodeId=071521e0381cc, content=请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=记录投稿经历, createdTime=Thu Nov 23 00:51:44 CST 2023, time=2023-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180385, encodeId=148821803851f, content=投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=Jagger, createdTime=Tue Jan 09 23:30:30 CST 2024, time=2024-01-09, status=1, ipAttribution=天津)]
    2023-11-23 记录投稿经历 来自广东省

    请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=921392, encodeId=693192139203, content=审稿速度:1.0<br>偏重的研究方向:白血病<br>经验分享:月初投了一篇,昨晚收到邮件分配稿号,今早登录系统一看,Decision in process,那感觉。。。。太提神了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200618/4c27fa23bb6a44a49a51871bc8fe6190/d1c485af61c8460ba037d35b90d34b04.jpg, createdBy=e5c95263798, createdName=嚯嚯嚯1971, createdTime=Sat Jan 30 15:57:20 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114616, encodeId=19812114616ba, content=我想问一下注册cancer letters 账号的时候title一栏应该填什么啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13335609339, createdName=ms5000002011942975, createdTime=Tue Feb 14 19:24:48 CST 2023, time=2023-02-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2091659, encodeId=19db209165937, content=求助,爱思维尔登录注册界面登录卡死怎么解决,一直注册不了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e83e5631686, createdName=雨落殇殇, createdTime=Mon Oct 03 23:21:05 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184614, encodeId=85ed218461406, content=刚投稿,血液肿瘤分子检测方向,不知道在不在期刊领域内;必须要提供推荐的审稿人,所有共同作者均需要邮件链接确认作者身份。提交完了之后很快under review,之后只更新了日期不更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78c76200857, createdName=195092_8956, createdTime=Mon Jan 29 11:53:34 CST 2024, time=2024-01-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2171958, encodeId=1f2321e19589a, content=09/10/2023 投稿<br>09/20/2023 under review <br>11/13/2023 2个审稿意见大修,编辑果断拒稿,毕业季投这个真的伤不起,本来不想曝光这个沙雕杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=651e8489728, createdName=ms2000000020645198, createdTime=Wed Nov 29 22:04:44 CST 2023, time=2023-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177808, encodeId=dc7f21e7808b8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;细胞生物学<br>经验分享:8.27投稿,9.7送审,一直审到12.7RRC,12.22DIP,12.27拒稿,两个审稿人给了三条大意见五条小意见,编辑以稿件太多为由拒稿,以前是个挺友好的杂志,现在谨慎投稿吧,耽误毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e088428858, createdName=ms3000001523418875, createdTime=Thu Dec 28 16:05:00 CST 2023, time=2023-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169383, encodeId=23cb2169383eb, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:10/21/2023 投稿<br>10/23/2023 改格式<br>10/23/2023 分配3个编辑<br>10/26/2023 Under Review<br>11/07/2023 Required Reviews Completed<br>11/10/2023 Decision in Process<br>11/13/2023 Major Revision 给了1个月修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9ce5721017, createdName=ms3000000772221561, createdTime=Sat Nov 18 21:22:58 CST 2023, time=2023-11-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173295, encodeId=0ea421e329515, content=偏重的研究方向:肿瘤<br>经验分享:20/11投稿 21/11重新推荐审稿人 23/11 with editor 05/12 DIP 感觉要拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Wed Dec 06 15:52:11 CST 2023, time=2023-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170381, encodeId=071521e0381cc, content=请问大家文章接受后多久会收到proof?接收一周了,还没收到proof邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=记录投稿经历, createdTime=Thu Nov 23 00:51:44 CST 2023, time=2023-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180385, encodeId=148821803851f, content=投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=Jagger, createdTime=Tue Jan 09 23:30:30 CST 2024, time=2024-01-09, status=1, ipAttribution=天津)]
    2024-01-09 Jagger 来自天津

    投稿10天了状态还是Submitted to journal,还没有分配编辑,请问有遇到这种情况的吗?是必须所有co-author都同意投稿吗?

    3

    展开3条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分